just thinking out loud. if you have a filter, the
Post# of 148331
Quote:
Our recent data that leronlimab crosses the blood-brain barrier with 70-75% receptor occupancy of the CCR5 receptors in the brain (Macaque model) is encouraging for the potential to enhance recovery in stroke and traumatic brain injury and explore a variety of central nervous system pathology.”
https://www.globenewswire.com/news-release/20....%E2%80%9D